Private equity firm GTCR announced the partnership it formed with Ed Fiorentino for the formation of Crealta Pharmaceuticas, Inc. This will be the second partnership between the Chicago-based private equity firm and Mr. Fiorentino. It can be recalled that Fiorentino served as the Chief Executive Officer of Actient Pharmaceuticals which was established through a partnership with GTCR in March 2009. Their new venture will center on the acquisition of specialty pharmaceutical firms and products to build an industry leader. Crealta is headquartered in Lake Forest, Illinois. To support the management strategy of the new firm, GTCR announced that it may pour up to USD 200 million in equity capital.

Fiorentino, who has extensive management experience at the senior level at Abbott Laboratories, will be Crealta's Chairman and Chief Executive Officer. He said he is looking forward to the partnership that seeks to build another pharmaceutical company. "The firm has a long history of backing experienced managers and providing them with the resources and support required to build successful companies through both organic growth and acquisitions."Fiorentino added.